EP Patent

EP0960621A2 — Pharmaceutical formulations comprising sildenafil

Assigned to Pfizer Inc · Expires 1999-12-01 · 26y expired

What this patent protects

Pharmaceutical formulations of the compound sildenafil.

USPTO Abstract

Pharmaceutical formulations of the compound sildenafil.

Drugs covered by this patent

vardenafil-hydrochloride (VARDENAFIL HYDROCHLORIDE)

Patent Metadata

Patent number: EP0960621A2
Jurisdiction: EP
Classification: —
Expires: 1999-12-01
Drug substance claim: No
Drug product claim: No
Assignee: Pfizer Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.